ESVS Guidelines: Section A--prevention in patients with carotid stenosis.
Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
Liapis
Christos D
CD
Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece. liapis@med.uoa.gr
Bell
Peter F
PF
Mikhailidis
Dimitri P
DP
Sivenius
Juhani
J
Nicolaides
Andrew
A
Fernandes e Fernandes
Jose
J
Biasi
Giorgio
G
Norgren
Lars
L
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology* / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control* / Q000628:therapy; D008078:Cholesterol, LDL; D000075202:Contraindications; D016903:Drug Monitoring; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
D000959:Antihypertensive Agents; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors